Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Preferred Stock Liabilities: 2015-2025

Historic Preferred Stock Liabilities for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to $7.9 million.

  • Wave Life Sciences' Preferred Stock Liabilities changed negligibly% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $7.9 million for FY2024, which is negligibly% changed negligibly from last year.
  • Wave Life Sciences' Preferred Stock Liabilities amounted to $7.9 million in Q3 2025, which was down 0.00% from $7.9 million recorded in Q2 2025.
  • Wave Life Sciences' 5-year Preferred Stock Liabilities high stood at $7.9 million for Q1 2021, and its period low was $7.9 million during Q1 2021.
  • Over the past 3 years, Wave Life Sciences' median Preferred Stock Liabilities value was $7.9 million (recorded in 2025), while the average stood at $7.9 million.